Episurf Medical (Nasdaq: EPIS B) today announces that the first surgery in Malaysia with the knee implant Episealer® has been scheduled.

“We are committed to developing our commercial strategy in the APAC region, we have started slowly, with a few market registrations of which Malaysia has been one, so it is exciting to get started here. Over the coming months we will invest in accelerating our commercial strategy for the APAC region. We appreciate the support we receive from our local partners and this partnership will get stronger as we grow,” comments Stephen Caswell, Head of Sales OUS, Episurf Medical.  

For more information, please contact:

Pål Ryfors, CEO, Episurf Medical
Tel:+46 (0) 709 62 36 69
Email: pal.ryfors@episurf.com

About Episurf Medical

Episurf Medical is endeavoring to bring people with painful joint injuries a more active, healthier life through the availability of minimally invasive and individualised treatment alternatives. Episurf Medical’s Episealer® individualised implants and Epiguide® surgical drill guides are developed for treating localised cartilage injury in joints. Episurf Medical’s μiFidelity® system enables implants to be cost-efficiently tailored to each individual’s unique injury for the optimal fit and minimal intervention. Episurf Medical’s head office is in Stockholm, Sweden. Its share (EPIS B) is listed on Nasdaq Stockholm. For more information, go to the company’s website: www.episurf.com.

https://news.cision.com/episurf/r/first-episealer–surgery-in-malaysia-scheduled,c3734927

https://mb.cision.com/Main/14691/3734927/1919039.pdf

(c) 2023 Cision. All rights reserved., source Press Releases – English